Key facts
- Zerigo Health’s last known valuation is $96.0M (Mar 2026).
- It has raised $117.6M across 1 recorded rounds; the latest was Early Stage VC ($43.0M) in Oct 2021.
- Notable investors include General Catalyst, CONNECT (San Diego), Texas Medical Center, SV Health Investors, Serra Ventures — 23 tracked in total.
- Zerigo Health has filed 1 Form D with the SEC, most recently Oct 2021 ($43.0M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Zerigo Health
Funding rounds
1 roundsAbout Zerigo Health
Developer of handheld phototherapy medical devices designed to treat chronic skin conditions. The company's devices treat skin diseases with narrowband UVB light therapy in the comfort of the home or while traveling, and can be connected to a smartphone application that controls the patient's prescription and therapy regimen, enabling patients to take treatments for conditions like eczema and psoriasis, receive treatment reminders, take photos to track progress, and consult doctors.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2014
- Employees
- 36
- Website
- zerigohealth.com/
- Ownership
- Privately Held (backing)
Zerigo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zerigo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zerigo Health in its N-PORT filings yet. We sweep new filings monthly.